Cargando…
The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
Endometrial cancer is one of the most common cancers of the reproductive organ in women. The incidence of it increases from year to year. In our study we assessed role of FGF21 and FGF23 in the diagnostics of patients with endometrial cancer. The study involved 182 patients, who were undergoing abra...
Autores principales: | Cymbaluk-Płoska, Aneta, Gargulińska, Paula, Chudecka-Głaz, Anita, Kwiatkowski, Sebastian, Pius-Sadowska, Ewa, Machaliński, Bogusław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344631/ https://www.ncbi.nlm.nih.gov/pubmed/32570721 http://dx.doi.org/10.3390/diagnostics10060414 |
Ejemplares similares
-
Could Galectin 3 Be a Good Prognostic Factor in Endometrial Cancer?
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2020) -
The Diagnostic Role of FGF 21 in Endometrial Cancer and Other Pathologies of the Uterine Corpus
por: Jagodzińska, Anna, et al.
Publicado: (2023) -
The role of lipocalin-2 serum levels in the diagnostics of endometrial cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2019) -
Circulating Serum Level of Visfatin in Patients with Endometrial Cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2018) -
Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2018)